2019 meeting of the global virus network.
Animals
Antiviral Agents
Arboviruses
/ drug effects
Climate Change
Communicable Diseases, Emerging
/ drug therapy
Coronavirus
/ drug effects
Ebolavirus
/ drug effects
Global Health
Hemorrhagic Fever, Ebola
/ drug therapy
Hepatitis B
/ drug therapy
Host-Pathogen Interactions
Humans
Influenza, Human
/ drug therapy
Internationality
One Health
/ trends
Pandemics
Viral Vaccines
Virus Diseases
/ drug therapy
Viruses
/ drug effects
Zoonoses
/ drug therapy
Climate change
Emerging viruses
Global virus network
Globalization
Pandemic
Journal
Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
30
10
2019
accepted:
02
11
2019
pubmed:
8
11
2019
medline:
16
7
2020
entrez:
8
11
2019
Statut:
ppublish
Résumé
The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 52 GVN Centers of Excellence and 9 Affiliate laboratories in 32 countries. The 11th International GVN meeting was held from June 9-11, 2019 in Barcelona, Spain and was jointly organized with the Spanish Society of Virology. A common theme throughout the meeting was globalization and climate change. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including severe virus epidemics, anticipation and preparedness for changing disease dynamics, host-pathogen interactions, zoonotic virus infections, ethical preparedness for epidemics and pandemics, one health and antivirals.
Identifiants
pubmed: 31697957
pii: S0166-3542(19)30619-9
doi: 10.1016/j.antiviral.2019.104645
pmc: PMC7127664
pii:
doi:
Substances chimiques
Antiviral Agents
0
Viral Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
104645Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.
Références
mBio. 2018 Oct 16;9(5):
pubmed: 30327438
Vaccine. 2018 May 3;36(19):2694-2704
pubmed: 29609966
PLoS Pathog. 2019 Apr 18;15(4):e1007640
pubmed: 30998804
Liver Int. 2018 Feb;38 Suppl 1:102-114
pubmed: 29427479
Infect Genet Evol. 2018 Dec;66:180-187
pubmed: 30292006
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1269-E1278
pubmed: 29358408
One Health. 2015 Dec 04;2:1-7
pubmed: 28616469
Eur J Epidemiol. 1988 Jun;4(2):256-8
pubmed: 2969825
Germs. 2019 Mar 01;9(1):35-42
pubmed: 31119115
J Med Chem. 2018 Sep 13;61(17):7419-7424
pubmed: 29745657
PLoS Genet. 2019 Oct 17;15(10):e1008271
pubmed: 31622336
Biochem Pharmacol. 2012 Jan 15;83(2):185-92
pubmed: 21889497
MMWR Morb Mortal Wkly Rep. 1999 Oct 1;48(38):845-9
pubmed: 10563521
Antiviral Res. 2018 Feb;150:20-29
pubmed: 29224735
mBio. 2014 Feb 18;5(1):
pubmed: 24549846
PLoS Negl Trop Dis. 2018 Apr 26;12(4):e0006353
pubmed: 29698487
Nucleic Acids Res. 2015 Feb 27;43(4):2259-70
pubmed: 25662223
Genetics. 2018 Dec;210(4):1151-1162
pubmed: 30523166
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31
pubmed: 29939980
Future Med Chem. 2019 Jul;11(13):1645-1657
pubmed: 31469331
ACS Infect Dis. 2018 Apr 13;4(4):605-619
pubmed: 29406692
Mech Ageing Dev. 1984 Nov;28(1):47-55
pubmed: 6513613
Nat Commun. 2019 May 27;10(1):2331
pubmed: 31133680
One Health. 2016 Nov 16;3:5-10
pubmed: 28616496
Viruses. 2019 Aug 05;11(8):
pubmed: 31387316
J Med Chem. 2014 May 22;57(10):4000-8
pubmed: 24800626
Euro Surveill. 2015 May 21;20(20):
pubmed: 26027485
Cell. 2003 Nov 14;115(4):449-59
pubmed: 14622599
Clin Liver Dis. 2016 Nov;20(4):737-749
pubmed: 27742011
Clin Microbiol Infect. 2018 Mar;24(3):221-228
pubmed: 29274465
Cancer Sci. 2011 Feb;102(2):295-301
pubmed: 21205073
Virology. 2018 Feb;515:235-242
pubmed: 29310105
J Med Chem. 2018 Nov 8;61(21):9442-9468
pubmed: 29920198
Lancet. 2012 Dec 1;380(9857):1936-45
pubmed: 23200502
Antiviral Res. 2016 Jun;130:69-80
pubmed: 26996139
Viruses. 2019 Sep 17;11(9):
pubmed: 31533244
Health Secur. 2019 Jul/Aug;17(4):344-351
pubmed: 31433280
Vaccine. 2012 May 2;30(21):3147-50
pubmed: 22421557
J Clin Immunol. 2011 Apr;31(2):137-46
pubmed: 21243520
Sci Rep. 2016 Aug 22;6:31819
pubmed: 27545976
Infect Genet Evol. 2012 Mar;12(2):461-6
pubmed: 22310302
PLoS Biol. 2019 Jun 11;17(6):e3000281
pubmed: 31185007
Microbiol Immunol. 2010 Feb;54(2):81-8
pubmed: 20377741
mBio. 2012 Nov 20;3(6):
pubmed: 23170002
Lancet Respir Med. 2014 Oct;2(10):813-22
pubmed: 25174549
Emerg Microbes Infect. 2019;8(1):1383-1392
pubmed: 31526243
EBioMedicine. 2018 Oct;36:92-102
pubmed: 30201444
Liver Int. 2017 Jan;37 Suppl 1:73-80
pubmed: 28052627
Antiviral Res. 2017 Aug;144:216-222
pubmed: 28619679
Clin Infect Dis. 2008 Apr 1;46(7):1078-84
pubmed: 18444828
Emerg Infect Dis. 2019 Oct;25(10):1932-1945
pubmed: 31538920
Virus Res. 2019 May;265:150-155
pubmed: 30922809
Adv Virus Res. 2015;93:47-160
pubmed: 26111586
Health Secur. 2017 May/Jun;15(3):253-260
pubmed: 28636442
PLoS Pathog. 2019 May 9;15(5):e1007760
pubmed: 31071193
BMC Med Ethics. 2017 Jun 26;18(1):43
pubmed: 28651650
Sci Adv. 2018 Aug 08;4(8):eaas9667
pubmed: 30101189
Virology. 2013 Jan 5;435(1):14-28
pubmed: 23217612